Načítá se...
IL-2-driven CD8(+) T cell phenotypes: implications for immunotherapy
The therapeutic potential of interleukin (IL)-2 in cancer treatment has been known for decades, yet its widespread adoption in clinical practice remains limited. Recently, chimeric proteins of an anti-PD-1 antibody and suboptimal IL-2 variants were shown to stimulate potent antitumor and antiviral i...
Uloženo v:
| Vydáno v: | Trends Immunol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2023
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615502/ https://ncbi.nlm.nih.gov/pubmed/37827864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2023.09.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|